Slice In Ixalan MTG Gathering The Magic: M/NM X4 Twain MTG Individual Cards


  1. Home
  2. Slice In Ixalan MTG Gathering The Magic: M/NM X4 Twain
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
Slice In Twain X4 M/NM Magic: The Gathering MTG Ixalan
Condition: New: A brand-new, unused, unopened, undamaged item (including handmade items). See the seller's Edition: Ixalan
Character Family: Magic The Gathering Card Rarity: Uncommon
Recommended Age Range: 3-80 years Language: English
Gender: Boys and Girls Regular or Foil: Regular
Original/ Reproduction: Original Trading Card Type: Magic The Gathering
Country of Manufacture: United States Brand:

Wizards of the Coast

UPC:

Does not apply

published on tue nov 09 2021

Slice In Ixalan MTG Gathering The Magic: M/NM X4 Twain MTG Individual Cards

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Slice In Ixalan MTG Gathering The Magic: M/NM X4 Twain MTG Individual Cards

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS